Compugen Ltd.
NASDAQ Global MarketTotal Valuation
Compugen Ltd. carries a market capitalization of 186.61M, placing it among publicly traded companies globally. Its enterprise value stands at 202.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 186.61M |
| Enterprise Value | 202.71M |
Share Statistics
Compugen Ltd. currently has 94.72M shares outstanding.
| Shares Outstanding | 94.72M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Compugen Ltd. trades at a trailing price-to-earnings ratio of 4.78.
| PE Ratio | 4.78 |
| PS Ratio | 2.83 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 2.84 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.18 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.84 |
| EV / EBITDA | 5.18 |
| EV / EBIT | 5.18 |
| EV / FCF | N/A |
Financial Position
Compugen Ltd. maintains a current ratio of 22.89, meaning it holds 22.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 22.89 |
| Quick Ratio | 22.80 |
| Debt / Equity | 16.09 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Compugen Ltd. posts a return on equity of 167.93 and a return on invested capital of 146.89.
| Return on Equity (ROE) | 167.93 |
| Return on Assets (ROA) | 79.22 |
| Return on Invested Capital (ROIC) | 146.89 |
| Return on Capital Employed (ROCE) | 158.56 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Compugen Ltd. has paid 45,000.00 in income taxes, reflecting an effective tax rate of 0.11.
| Income Tax | 45,000.00 |
| Effective Tax Rate | 0.11 |
Stock Price Statistics
Compugen Ltd.'s stock has gained approximately 7.06522% over the past 52 weeks. The 50-day moving average sits at 2.40, while the 200-day moving average is 2.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.06522% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 2.29 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Compugen Ltd. generated 71.40M in revenue and converted that into 42.20M in net income, yielding earnings per share of 0.45. EBITDA reached 39.13M, while operating income came in at 39.13M.
| Revenue | 71.40M |
| Gross Profit | 64.39M |
| Operating Income | 39.13M |
| Pretax Income | 42.24M |
| Net Income | 42.20M |
| EBITDA | 39.13M |
| EBIT | 39.13M |
| Earnings Per Share (EPS) | 0.45 |
Margins
Compugen Ltd. operates with a gross margin of 90.18, reflecting its pricing power and cost economics. The operating margin of 54.81 and net profit margin of 59.10 provide insight into operational efficiency.
| Gross Margin | 90.18 |
| Operating Margin | 54.81 |
| Pretax Margin | 59.16 |
| Profit Margin | 59.10 |
| EBITDA Margin | 54.81 |
Scores
Compugen Ltd. posts an Altman Z-Score of 5.43, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.43 |